Please assess the completion status of the following clinical trial:

Trial Title: Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* It was recommended that the patient's treatment was in accordance with the local marketing authorization (MA) for Neupro®~* The patient must have a diagnosis of moderate to severe idiopathic RLS~* The patient is considered reliable and capable of adhering to the visit schedule or medication administration according to the judgment of the investigator~* The decision to prescribe the drug has been made by the physician independently of his/her decision to include the patient in the study~* Subject is informed and given ample time and opportunity to think about his/her participation in the study and has given written informed data consent~Exclusion Criteria:~* Hypersensitivity to the active substance or to any of the excipients~* Magnetic resonance imaging or cardioversion (see SmPC)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neupro® (Type: None): Routine treatment in accordance with the local marketing authorization for Neupro® in RLS

Based on this trial design, predict the completion outcome and termination type (if applicable).